US equities |
NVDA $239.76 ▲+2.49% SPCX $169.66 ▲+6.73% MU $1,060.25 ▼-1.36% TSLA $380.92 ▲+2.79% SNDK $1,692.67 ▼-1.59% MSFT $528.50 ▲+2.12% INTC $116.44 ▼-2.43% META $743.64 ▲+2.14%
FinancialContent

Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

53.01 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Soleno Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
SLNO CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Lead Plaintiff Deadline on May 5, 2026
NEW YORK, NY - March 13, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Lawsuit
News headline image
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action filed by Robbins Geller Rudman & Dowd LLP
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
SOLENO THERAPEUTICS DEADLINE: Investors of Soleno Therapeutics, Inc. (SLNO) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
SOLENO THERAPEUTICS DEADLINE: Investors of Soleno Therapeutics, Inc. (SLNO) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2026
NEW YORK, NY - March 12, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Lawsuit
News headline image
SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Soleno Therapeutics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Law Offices of Howard G. Smith Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Law Offices of Frank R. Cruz Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Deadline to Lead in Securities Fraud Lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) is May 5, 2026 - Contact Kaplan Fox
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Deadline to Lead in Securities Fraud Lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) is May 5, 2026 - Contact Kaplan Fox
NEW YORK, NY - March 11, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
ROSEN, LEADING INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
SOLENO THERAPEUTICS, INC. (SLNO) INVESTOR ALERT Investors With Large Losses in Soleno Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Kaplan Fox Alerts Investors to a Securities Class Action Against Soleno Therapeutics, Inc. (SLNO) - Deadline is May 5, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Alerts Investors to a Securities Class Action Against Soleno Therapeutics, Inc. (SLNO) - Deadline is May 5, 2026
NEW YORK, NY - March 10, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Lawsuit
News headline image
Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SLNO
From DJS Law Group
Via Business Wire
News headline image
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into Soleno Therapeutics, Inc. (SLNO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Kaplan Fox Encourages Investors of Soleno Therapeutics, Inc. (SLNO) to Contact the Firm Before Lead Plaintiff Deadline on May 5, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Encourages Investors of Soleno Therapeutics, Inc. (SLNO) to Contact the Firm Before Lead Plaintiff Deadline on May 5, 2026
NEW YORK, NY - March 9, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Lawsuit
News headline image
Securities Fraud Investigation Into Soleno Therapeutics, Inc. (SLNO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
SOLENO LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Rosen Law Firm Urges Soleno Therapeutics, Inc. (NASDAQ: SLNO) Stockholders to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >